Table 2.

Life expectancy by frailty state in women and men by 5-year age group in the SIPAF study

Gender	Age at start of the interval	N	Total life expectancy	Robust		Pre-frail		Frail		Dependent
				Life expectancy in years with 95% CI	% of total life expectancy	Life expectancy in years with 95% CI	% of total life expectancy	Life expectancy in years with 95% CI	% of total life expectancy	Life expectancy in years with 95% CI	% of total life expectancy
Women	70	197	18.34	5.12 [4.63–5.60]	27.9	7.41 [6.89–7.94]	40.4	3.40 [3.02–3.79]	18.5	2.41 [2.11–2.71]	13.1
	75	261	14.27	3.24 [2.87–3.61]	22.7	5.59 [5.16–6.02]	39.2	3.02 [2.68–3.36]	21.2	2.42 [2.12–2.71]	17.0
	80	299	10.53	1.64 [1.37–1.91]	15.6	4.00 [3.65–4.35]	38.0	2.62 [2.32–2.93]	24.9	2.27 [1.99–2.54]	21.6
	85	288	7.35	0.74 [0.56–0.93]	10.1	2.53 [2.25–2.82]	34.4	2.00 [1.73–2.26]	27.2	2.08 [1.82–2.34]	28.3
	90	209	5.04	0.28 [0.15–0.40]	5.6	1.42 [1.17–1.67]	28.2	1.49 [1.24–1.74]	29.6	1.85 [1.59–2.12]	36.7
	95	141	3.34	0.15 [0.03–0.27]	4.5	0.60 [0.28–0.82]	18.0	1.12 [0.86–1.39]	33.5	1.47 [1.19–1.75]	44.0
Men	70	178	14.76	6.35 [5.85–6.86]	43.0	5.97 [5.47–6.47]	40.4	1.21 [0.97–1.46]	8.2	1.23 [0.98–1.48]	8.3
	75	227	11.35	4.16 [3.75–4.57]	36.7	4.73 [4.32–5.15]	41.7	1.25 [1.00–1.50]	11.0	1.21 [0.96–1.45]	10.7
	80	221	8.33	2.69 [2.35–3.03]	32.3	3.50 [3.13–3.86]	42.0	1.06 [0.82–1.29]	12.7	1.08 [0.84–1.31]	13.0
	85	167	5.80	1.40 [1.11–1.69]	24.1	2.33 [2.00–2.66]	40.2	1.09 [0.83–1.35]	18.8	0.98 [0.74–1.22]	16.9
	90	111	4.00	0.81 [0.55–1.06]	20.3	1.62 [1.30–1.93]	40.5	0.57 [0.35–0.79]	14.3	1.00 [0.72–1.27]	25.0
	95	51	2.73	0.63 [0.30–0.95]	23.1	0.91 [0.55–1.28]	33.3	0.51 [0.21–0.82]	18.7	0.68 [0.35–1.02]	24.9